Ruti Aga: Six-year ban for fake prescription issued by family member

Last week, a small detail in an Athletics Integrity Unit (AIU) press release stood out: a clinic that did not exist, a ‘doctor’ who was a family member with no medical registration, and an old prescription pad that the clinic explicitly disowned. This is a real case. It is the basis of Ethiopian marathon runner Ruti Aga’s six-year ban. When I read the statement, one question came to mind: if the injection was legal, why forge the prescription? Aga won the 2026 Tokyo Marathon and has three second-place finishes at World Marathon Majors. She tested positive after winning a half marathon in China in March. The AIU announced on Thursday that she has been banned for six years—two for the presence of the substance, four for tampering. The ban runs from 10 September, the date of her provisional suspension. I found the bedroom mic before I found the crowd, and both taught me timing—this case is also about timing, but in reverse. This case belongs to the world of anti-doping where the arithmetic of sanctions is clear, but the human story is far more tangled. First, a technical correction. Many media reports called methylprednisolone a ‘prohibited steroid,’ which is wrong. It is a glucocorticoid, WADA Prohibited List class S9. S9 glucocorticoids are prohibited only in-competition—by injection, oral, or rectal routes. A knee injection out-of-competition is entirely legal; it becomes a violation only if residues are present in-competition. That is the legal hinge of this case. Aga’s defence could have been that she received an injection for a knee injury, the timing and route were correct, and medical records exist. But she forged the prescription—and that destroyed her defence. The AIU investigation found the prescription was in the name of a clinic that did not exist. The ‘doctor’ was a family member with no medical registration. He claimed to have used ‘an old prescription pad from a former workplace’—but the clinic explicitly disowned the pad. Three independent verification failures. This is the signature of an athlete operating without a credentialed team physician. The spectator in the stand will ask: if the injection was legal, why forge the prescription? That question is the heart of this case. In Chennai in 2026, after my hamstring tear, I learned what the body’s limit feels like. Knee injuries are common among marathoners. Glucocorticoid injections are the cheapest, most available tool to mask that pain. But a credentialed team physician, a TUE application, and the correct washout period—none were present. The forged prescription is a symptom of that gap, not the cause. The sanction arithmetic: two years for the presence violation, four years for tampering. This is consistent with standard WADA Code provisions. The two years means the panel found the substance was present but did not prove intentional cheating—otherwise the sanction would be higher. Four years is the standard for tampering. But note: the panel did not grant a ‘no significant fault’ reduction, because forging a prescription is itself evidence of concealment. The paradox is that the fake document did not increase the presence sanction, but it fully proved tampering. Aga is 32. A six-year ban removes her until age 38. Ethiopia’s women’s marathon depth is so extreme that even a 2:18–2:20 runner is not automatically selected. At 38, with a doping record, there is no route back. This ban is effectively a lifetime ban. Her 2026 Tokyo title and three Major second places will remain in the record unless earlier use is found. But the result and prize money from the March Chinese half marathon—which the AIU has not clarified—are likely to be annulled. This case goes beyond steroid cheating. It is a story of medical governance failure inside East African road-racing entourages. The AIU’s enforcement frontier has shifted from ‘detection’ to ‘document verification.’ Aga’s case is not an outlier; it belongs to a family of cases where an initial substance violation is compounded by a fabricated explanation. China’s label-race circuit is now a high-scrutiny zone. Large appearance-fee budgets, deep East African elite fields, and AIU testing all collide in the same race. The race Aga won in March was almost certainly a World Athletics Label road race with in-competition testing. That is where the appearance-fee economy and the testing economy meet. A six-year ban for a substance with no proven endurance benefit may seem disproportionate. But the real basis of the sanction is tampering. The AIU has sent a clear message: lying and fabricating documents cost more than the substance itself. This is the reality of a sport where athletes lack expensive medical support and fall into cheap alternatives. Twenty-nine medals in a shoebox; the torn hamstring taught me the rest. The question is not whether Aga is guilty—she is, and she destroyed her own defence. The question is: how many other athletes in the same training clusters are using informal medical networks? One fake prescription was caught, but the hands that made it are still part of the system. Next time an Ethiopian or Kenyan runner takes the field with knee pain, ask: which doctor do they have, and where is that doctor registered? The sport needs medical support more than punishment.